| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.15B | 3.05B | 3.07B | 2.45B | 1.51B | 686.30M |
| Gross Profit | 1.65B | 1.96B | 570.60M | 1.58B | 997.60M | 450.90M |
| EBITDA | 540.40M | 616.30M | 603.90M | 151.70M | -300.00K | -514.00M |
| Net Income | 154.80M | 309.70M | 188.20M | -271.20M | -422.80M | -616.80M |
Balance Sheet | ||||||
| Total Assets | 4.44B | 5.07B | 4.84B | 4.82B | 5.23B | 5.56B |
| Cash, Cash Equivalents and Short-Term Investments | 461.30M | 1.06B | 849.10M | 674.50M | 707.30M | 655.34M |
| Total Debt | 3.10B | 3.46B | 3.55B | 3.78B | 3.95B | 3.93B |
| Total Liabilities | 4.04B | 4.46B | 4.52B | 4.70B | 4.90B | 4.76B |
| Stockholders Equity | 383.40M | 594.40M | 309.80M | 110.20M | 322.90M | 787.97M |
Cash Flow | ||||||
| Free Cash Flow | 278.50M | 315.20M | 294.80M | 25.30M | 70.70M | -414.00M |
| Operating Cash Flow | 444.70M | 466.00M | 444.30M | 136.00M | 166.20M | -330.10M |
| Investing Cash Flow | -156.40M | -146.90M | -131.80M | -96.30M | -89.30M | -83.40M |
| Financing Cash Flow | -770.20M | -103.10M | -125.40M | -52.20M | -19.90M | 584.40M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | $1.94B | 50.40 | 12.38% | ― | 9.30% | 67.19% | |
67 Neutral | $3.46B | 28.68 | 32.60% | 0.90% | 9.70% | -31.62% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
57 Neutral | $458.03M | 64.94 | 1.68% | 1.88% | 6.28% | ― | |
47 Neutral | ― | ― | ― | ― | -2.85% | 75.96% | |
45 Neutral | $1.13B | ― | ― | ― | 9.74% | 12.29% | |
42 Neutral | ― | ― | ― | ― | -2.85% | 75.96% |
Cinemark’s recent earnings call painted a picture of strategic success and financial resilience, despite facing some notable challenges. The company celebrated significant achievements such as the extinguishment of COVID-related debt and gains in market share, while also acknowledging hurdles like decreased attendance and rising costs.
Cinemark Holdings, Inc., headquartered in Plano, Texas, is one of the largest and most influential theatrical exhibition companies globally, operating 497 theaters across 14 countries. The company is known for its premium movie-going experiences, including luxury seating and diverse food options.
On November 5, 2025, Cinemark Holdings announced its third-quarter financial results, reporting a total revenue of $858 million and a net income of $51 million. The company eliminated all pandemic-related debt and introduced a $300 million share repurchase program, alongside a 12.5% increase in its quarterly dividend. Cinemark’s strong performance was highlighted by record-breaking results in market share and box office revenues, reflecting its strategic initiatives and financial strength. The share repurchase program aims to mitigate dilution from equity awards and warrants, demonstrating confidence in the company’s long-term prospects.
The most recent analyst rating on (CNK) stock is a Hold with a $29.00 price target. To see the full list of analyst forecasts on Cinemark Holdings stock, see the CNK Stock Forecast page.
On August 15, 2025, Cinemark Holdings entered into warrant unwind and termination agreements with its counterparties, related to previously issued convertible senior notes from 2020. These agreements involve delivering a mix of cash and common stock to the counterparties, with the settlement based on the company’s stock price over a specified observation period.
The most recent analyst rating on (CNK) stock is a Buy with a $34.00 price target. To see the full list of analyst forecasts on Cinemark Holdings stock, see the CNK Stock Forecast page.
On August 13, 2025, Cinemark Holdings, Inc. announced that its Board of Directors declared a quarterly cash dividend of $0.08 per share, payable on September 10, 2025, to stockholders of record as of August 27, 2025. This announcement reflects Cinemark’s ongoing commitment to returning value to its shareholders and may positively impact investor confidence in the company’s financial health and strategic direction.
The most recent analyst rating on (CNK) stock is a Buy with a $34.00 price target. To see the full list of analyst forecasts on Cinemark Holdings stock, see the CNK Stock Forecast page.